MYDA Advisors LLC
- SEC CIK
- 0001589689
- Latest filing
- Aug 13, 2026
ARQT holding history
Arcutis Biotherapeutics, Inc. in every 13F filed by MYDA Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARQT overviewAll 13F holders of ARQTFull Q2 2026 holdings
- Shares (Q2 2026)
- 240,000
- Value
- $6.29M
- % of portfolio
- 1.5%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 240,000 | $6.29M | 1.5% | 00.0% | Unchanged | Holders |
| Q1 2026 | 240,000 | $5.65M | 1.3% | −25,000−9.4% | Reduced | Holders |
| Q4 2025 | 265,000 | $7.70M | 2.2% | −205,000−43.6% | Reduced | Holders |
| Q3 2025 | 470,000 | $8.86M | 2.7% | +100,000+27.0% | Added | Holders |
| Q2 2025 | 370,000 | $5.19M | 1.5% | +80,000+27.6% | Added | Holders |
| Q1 2025 | 290,000 | $4.54M | 1.6% | +90,000+45.0% | Added | Holders |
| Q4 2024 | 200,000 | $2.79M | 0.8% | +80,000+66.7% | Added | Holders |
| Q3 2024 | 120,000 | $1.12M | 0.3% | +45,000+60.0% | Added | Holders |
| Q2 2024 | 75,000 | $697.5K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 75,000 | $743.3K | 0.3% | −145,000−65.9% | Reduced | Holders |
| Q4 2023 | 220,000 | $710.6K | 0.3% | +220,000 | New | Holders |